Latest News about MRNA
Recent news which mentions MRNA
From MarketWatch
The 3 Best Healthcare Stocks to Buy in August
August 09, 2023
From InvestorPlace
3 Healthcare Stocks to Sell in August Before They Crash and Burn
August 09, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
August 04, 2023
From Benzinga
Moderna Lifts 2023 COVID-19 Vaccine Sales Outlook, Despite Over 90% Fall In Q2 Sales
August 03, 2023
Tickers
MRNA
From Benzinga
Moderna’s stock jumps 5% premarket after narrower-than-expected loss and revenue beat
August 03, 2023
From MarketWatch
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
From Benzinga
Apple and Amazon results may hold the key to any market rebound. Here’s the technical set-up.
August 03, 2023
From MarketWatch
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
August 02, 2023
From InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
From Benzinga
3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now
August 01, 2023
From InvestorPlace
Why Novavax Stock Zoomed 13% Higher on Monday
July 31, 2023
From Motley Fool
7 Stocks to Buy Before They Surpass 2021 Highs
July 31, 2023
From InvestorPlace
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
July 31, 2023
From Benzinga
From Benzinga
Tags
NASDAQ:RLMD,NYSE:DNA,OTCMKTS:VRAYQ,NASDAQ:MRNA,NYSE:PFE,NASDAQ:AIMD,NASDAQ:IOVA
Market News
AIMD
From InvestorPlace
As COVID-19 Cases Spike This Summer, Healthcare Experts See It As Recurring Theme And Recommend These Measures
July 29, 2023
From Benzinga
Worried about Lyme disease? CDC warns that 450,000 people may have been infected by a tick-related meat allergy.
July 28, 2023
Tickers
MRNA
Tags
MRNA
From MarketWatch
From Motley Fool
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
July 26, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.